Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines

Journal of the National Comprehensive Cancer Network : JNCCN
R T HoppeNational comprehensive cancer network

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin Lymphoma (HL) include the clinical management of classical HL and lymphocyte-predominant HL (LPHL). Major changes have been incorporated into these guidelines since their inception. In the 2012 NCCN Guidelines for HL, PET scans are not recommended for interim restaging of patients with stage I to II favorable disease. After reevaluating the available evidence on the use of interim PET imaging, the panel recommends the use of diagnostic CT scan of involved sites for interim restaging after completion of chemotherapy for this group of patients. Maintenance rituximab for 2 years is included as an option for patients with stage IB to IIB or stage III to IV LPHL treated with rituximab alone in the first-line setting. Brentuximab vedotin is included as an option for patients with progressive disease or relapsed disease after second-line chemotherapy or high-dose therapy with autologous stem cell rescue.

Associated Clinical Trials

Citations

Aug 5, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dennis A EichenauerAndreas Engert
Jul 22, 2016·Advances in Anatomic Pathology·Sergio Piña-Oviedo, Cesar A Moran
Jan 7, 2018·Cancer Chemotherapy and Pharmacology·Ira Kantrowitz-GordonMary F Hebert
Jul 11, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie SasseBastian von Tresckow
Apr 23, 2014·Expert Opinion on Pharmacotherapy·Dennis A EichenauerVolker Diehl
Feb 6, 2014·British Journal of Haematology·Girish VenkataramanVolker Diehl
May 20, 2016·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Karoline PilzMechthild Krause
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joachim Yahalom
Oct 12, 2012·International Journal of Hematology·Dennis A Eichenauer, Andreas Engert
Feb 26, 2016·Current Treatment Options in Cardiovascular Medicine·Anne BlaesPeter Hurley
Apr 18, 2016·International Journal of Hematology·Shinichi MakitaKensei Tobinai
Sep 24, 2015·Nuclear Medicine and Molecular Imaging·Tsung-Han YangShiou-Chi Cherng
Jan 29, 2017·Journal of the National Cancer Institute·Yiwey ShiehUNKNOWN Athena Breast Health Network Investigators
May 7, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten KobeMarkus Dietlein
Feb 18, 2014·International Journal of Hematology·Bhagirathbhai DholariaKonstantinos Arnaoutakis
Jul 15, 2015·Future Oncology·Jonathon B CohenChristopher R Flowers
Jul 18, 2015·Clinical Case Reports·Wan-Shan LiKung-Chao Chang
Nov 16, 2018·La Radiologia medica·Giuseppe PetraliaUNKNOWN Italian Working Group on Magnetic Resonance
Feb 6, 2019·Scientific Reports·Sarah A MilgromGrace L Smith
Mar 17, 2015·Current Medical Research and Opinion·Vijayveer BonthapallyDirk Huebner
Sep 23, 2018·Journal of Global Oncology·Rachel Bender IgnacioWarren Phipps
Sep 3, 2020·Blood·Dennis A Eichenauer, Andreas Engert
Jan 28, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Colette ZwarthoedAndrea Gallamini
Apr 1, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ferdinand SeithNina Schwenzer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.